CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-19 | de los Pinos Elisabet See Remarks | Grant or award | +121,875 | 190,526 | ||
| 2023-01-19 | de los Pinos Elisabet See Remarks | Grant or award · Stock Option (Right to Buy) | +187,500 | 187,500 | ||
| 2023-01-19 | Rich Cadmus See Remarks | Grant or award | +34,125 | 58,703 | ||
| 2023-01-19 | Rich Cadmus See Remarks | Grant or award · Stock Option (Right to Buy) | +52,500 | 52,500 | ||
| 2023-01-06 | Johnson David Michael Director | Purchase | +700 | $10.50 | $7K | 18,000 |
| 2023-01-06 | Johnson David Michael Director | Purchase | +904 | $10.51 | $10K | 18,000 |
| 2023-01-05 | Johnson David Michael Director | Purchase | +300 | $10.00 | $3K | 17,300 |
| 2023-01-05 | Johnson David Michael Director | Purchase | +96 | $10.00 | $960 | 17,096 |
| 2022-12-28 | Johnson David Michael Director | Purchase | +2,000 | $9.75 | $20K | 17,000 |
| 2022-12-28 | Johnson David Michael Director | Purchase | +2,000 | $9.75 | $20K | 17,000 |
| 2022-12-05 | Matrix Capital Management Company, LP 10% owner | Purchase | +1,250,000 | $12.00 | $15.0M | 5,362,870 |
| 2022-12-01 | Johnson David Michael Director | Purchase | +5,000 | $12.37 | $62K | 15,000 |
| 2022-12-01 | Johnson David Michael Director | Purchase | +5,000 | $12.37 | $62K | 15,000 |
| 2022-10-31 | Feder Julie B Chief Financial Officer | Sale | −2,015 | $12.45 | $25K | 24,235 |
| 2022-10-31 | Rich Cadmus See Remarks | Sale | −1,672 | $12.45 | $21K | 24,578 |
| 2022-10-31 | de los Pinos Elisabet See Remarks | Sale | −5,706 | $12.46 | $71K | 68,651 |
| 2022-10-31 | De Rosch Mark Chief Operating Officer | Sale | −1,115 | $12.46 | $14K | 16,385 |
| 2022-06-15 | PAREKH RAJESH B Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2022-06-15 | Johnson David Michael Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2022-06-15 | Srivastava Sapna Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 |
Page 9 of 11 · 219 trades